ArticleFrontiers in oncology2025
Clinical evaluation, motor performance and quality of life in patients affected by Soft Tissue Sarcomas undergoing surgical treatment: observational study.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Soft Tissue Sarcomas (STSs) are rare malignant tumors characterized by a marked histological heterogeneity. Their standard of care is the surgical resection with adjuvant therapies, but these interventions induce sensorimotor impairments, pain, and a reduction quality of life. In this context, systematic evidence on its role in STS patients is currently lacking. This prospective, multicenter, observational study aims to evaluate the effects of a personalized rehabilitation protocol on clinical characteristics, motor performance, and quality of life in patients undergoing surgery for STS of the trunk and lower limbs. Patients will be recruited and assessed at four time-points: baseline (pre-surgery), post-surgery (within 7 days post-surgery), pre-rehabilitation (within 30 days post-surgery), and post-rehabilitation (within 90 days post-surgery). Rehabilitation will combine conventional physiotherapy with robotic technologies, delivered over two daily sessions for approximately 60 days. The assessments will include gait analysis, clinical scales, and patient-oriented questionnaires. The primary endpoint will be the improvement in functional status quantified in terms of Toronto Extremity Salvage Score differentiated for the Lower Limb, while secondary outcomes will include biomechanical parameters, pain, and quality of life. This trial will represent the first study quantifying the impact of rehabilitation in patients with STS, with the potential to generate novel prognostic factors and provide an evidence-based framework for future tailored rehabilitation protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.